The median time to worsening performance status ( a change in Eastern Cooperative Oncology Group performance status -LSB- on a scale of @ to @ , with @ indicating no symptoms and higher numbers indicating increasing degrees of disability -RSB- from @ or @ to @ or more ) was @ months with TAS-@ versus @ months with placebo ( hazard ratio , @ ; @ % CI , @ to @ ; P < @ ) .